Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Thorac Oncol
2016 Nov 01;1111:1891-1900. doi: 10.1016/j.jtho.2016.06.001.
Show Gene links
Show Anatomy links
Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.
Jang JS
,
Wang X
,
Vedell PT
,
Wen J
,
Zhang J
,
Ellison DW
,
Evans JM
,
Johnson SH
,
Yang P
,
Sukov WR
,
Oliveira AM
,
Vasmatzis G
,
Sun Z
,
Jen J
,
Yi ES
.
???displayArticle.abstract???
INTRODUCTION: We performed a genomic study in lung adenocarcinoma cases with discordant anaplastic lymphoma receptor tyrosine kinase gene (ALK) status by fluorescent in situ hybridization (FISH) and immunohistochemical (IHC) analysis.
METHODS: DNA from formalin-fixed paraffin-embedded tissues of 16 discordant (four FISH-positive/IHC-negative and 12 FISH-negative/IHC-positive) cases by Vysis ALK Break Apart FISH and ALK IHC testing (ALK1 clone) were subjected to whole gene capture and next-generation sequencing (NGS) of nine genes, including ALK, echinoderm microtubule associated protein like 4 gene (EML4), kinesin family member 5B gene (KIF5B), staphylococcal nuclease and tudor domain containing 1 gene (SND1), BRAF, ret proto-oncogene (RET), ezrin gene (EZR), ROS1, and telomerase reverse transcriptase (TERT). All discordant cases (except one FISH-negative/IHC-positive case without sufficient tissue) were analyzed by IHC with D5F3 antibody. In one case with fresh frozen tissue, whole transcriptome sequencing was also performed. Twenty-six concordant (16 FISH-positive/IHC-positive and 10 FISH-negative/IHC-negative) cases were included as controls.
RESULTS: In four ALK FISH-positive/IHC-negative cases, no EML4-ALK fusion gene was observed by NGS, but in one case using fresh frozen tissue, we identified EML4-baculoviral AIP repeat containing 6 gene (BIRC6) and AP2 associated kinase 1 gene (AAK1)-ALK fusion genes. Whole transcriptome sequencing revealed a highly expressed EML4-BIRC6 fusion transcript and a minimally expressed AAK1 transcript. Among the 12 FISH-negative/IHC-positive cases, no evidence of ALK gene rearrangement was detected by NGS. Eleven of 12 FISH-negative/IHC-positive cases detected by ALK1 clone were concordant by repeat ALK IHC with D5F3 antibody (i.e., FISH-negative/IHC-negative by D5F3 clone). Among the 16 ALK FISH-positive/IHC-positive positive controls, whole gene capture identified ALK gene fusion in 15 cases, including in one case with Huntington interacting protein 1 gene (HIP1)-ALK. No ALK fusion gene was observed in any of the 10 FISH-negative/IHC-negative cases. Other fusion genes involving ROS1, EZR, BRAF, and SND1 were also found.
CONCLUSIONS: ALK FISH results appeared to be false-positive in three of four FISH-positive/IHC-negative cases, whereas no false-negative ALK FISH case was identified among 12 ALK FISH-negative/IHC-positive cases by ALK1 clone, which was in keeping with the concordant FISH-negative/IHC-negative status by D5F3 clone. Our targeted whole gene capture approach using formalin-fixed paraffin embedded samples was effective for detecting rearrangements involving ALK and other actionable oncogenes.
Asmann,
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines.
2011, Pubmed
Asmann,
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines.
2011,
Pubmed
Boland,
MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.
2013,
Pubmed
Chihara,
More on crizotinib.
2011,
Pubmed
Drucker,
BIMA V3: an aligner customized for mate pair library sequencing.
2014,
Pubmed
Fang,
HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
2014,
Pubmed
Hong,
HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
2014,
Pubmed
,
Echinobase
Jang,
Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers.
2015,
Pubmed
Karolchik,
The UCSC Genome Browser.
2012,
Pubmed
Kim,
Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
2011,
Pubmed
Lantuejoul,
French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
2015,
Pubmed
Li,
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.
2013,
Pubmed
Li,
Fast and accurate short read alignment with Burrows-Wheeler transform.
2009,
Pubmed
Lipson,
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
2012,
Pubmed
Martinez,
Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients.
2013,
Pubmed
McLeer-Florin,
Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.
2012,
Pubmed
Minca,
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.
2013,
Pubmed
Mino-Kenudson,
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.
2010,
Pubmed
Murakami,
A Screening Method for the ALK Fusion Gene in NSCLC.
2012,
Pubmed
,
Echinobase
Murphy,
Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.
2014,
Pubmed
Ou,
Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.
2014,
Pubmed
Paik,
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.
2012,
Pubmed
Pekar-Zlotin,
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
2015,
Pubmed
Peled,
Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
2012,
Pubmed
Ross,
Whole cancer genome sequencing by next-generation methods.
2011,
Pubmed
Shaw,
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.
2016,
Pubmed
Sholl,
Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas.
2013,
Pubmed
Takeuchi,
RET, ROS1 and ALK fusions in lung cancer.
2012,
Pubmed
Vasmatzis,
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.
2012,
Pubmed
Wang,
CREST maps somatic structural variation in cancer genomes with base-pair resolution.
2011,
Pubmed
Yi,
Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.
2011,
Pubmed
Yoshida,
Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas.
2011,
Pubmed
Zheng,
Anchored multiplex PCR for targeted next-generation sequencing.
2014,
Pubmed
von Laffert,
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making.
2015,
Pubmed
von Laffert,
Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
2014,
Pubmed
